New Drug for Wet Age-Related Macular Degeneration in Research Phase
Currently, a condition called “wet” age-related macular degeneration (AMD) is the most common cause of blindness in people over 50. It’s the more severe form of macular degeneration. Available treatment for this form of the disease can sometimes slow its progression, but the disease often returns, sometimes more strongly than before. And the current treatment can’t reverse the progression of wet AMD.
Researchers are excited about a new drug called squalamine. Other drugs are also in the research phase for wet AMD, but they will require a needle in the eye.
Squalamine, on the other hand, if approved, will be administered through a vein. And the drug seems to be able not only to stop the progression of wet AMD, but to restore some vision as well.
Squalamine is not yet available, but be sure to ask you doctor about it.
Reuters Health Information, 6 August 2003.